Bedrijfsvoering Novartis AG

NOVN

CH0012005267

Farmaceutische producten

Beurs gesloten - Swiss Exchange Andere beurzen 17:30:03 23-01-2026			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
115,64 ^CHF	+0,47%		+0,03%	+5,51%

09:24	Indiaas Cipla boekt sterker dan verwachte kwartaalwinstdaling door leveringsproblemen bij tumormedicijn	RE
22/01	Europa belangrijke bedrijven - Telenor stijgt met 8,1 procent	FW

Uitvoerend comité: Novartis AG

Bedrijfsleider

Beklede functiesVan

Vasant Narasimhan

50 jaar

Chief Executive Officer

01-02-2018

Teresa Jose

Comptroller/Controller/Auditor

01-07-2025

Shreeram Aradhye

64 jaar

Chief Tech/Sci/R&D Officer

16-05-2022

Robert Kowalski

58 jaar

Human Resources Officer

01-09-2021

Charlotte Pamer-Wieser

Corporate Secretary

01-09-2011

Karen Hale

58 jaar

Compliance Officer	14-04-2025
General Counsel	15-05-2021

Steffen Lang

59 jaar

Chief Operating Officer

04-04-2022

Harry Werner Kirsch

61 jaar

Director of Finance/CFO

24-04-2013

Samenstelling van de raad van bestuur: Novartis AG

Directeur

RadenVan

Giovanni Caforio

61 jaar

Compensation Committee
HR Committee
Governance Committee
Nominating Committee

Bridgette Heller

64 jaar

Compensation Committee Chair	13-09-2019
Audit Committee	28-02-2020
Compensation Committee	28-02-2020
Governance Committee	02-02-2021
Nominating Committee	02-02-2021
Finance Committee

Nancy Andrews

67 jaar

Governance Committee Chair	20-05-2025
Nominating Committee Chair	20-05-2025
Compensation Committee	01-02-2021

Patrice Bula

70 jaar

Compensation Committee	28-02-2019
Governance Committee Chair	28-02-2019
Nominating Committee Chair	28-02-2019

Simon Moroney

67 jaar

Compensation Committee Chair	28-02-2020
Compensation Committee	01-04-2021
Nominating Committee	01-04-2021

Daniel Hochstrasser

66 jaar

Audit Committee	04-03-2022
Governance Committee	04-03-2022
Nominating Committee	04-03-2022

John Young

62 jaar

Audit Committee
Governance Committee
Compensation Committee	07-03-2025

Ana de Pro Gonzalo

59 jaar

Audit Committee	04-03-2022
Compensation Committee	04-12-2021
Audit Committee Chair	01-06-2020

Frans van Houten

65 jaar

Audit Committee
Governance Committee Chair
Nominating Committee Chair

Liz Doherty

69 jaar

Audit Committee Chair

10-05-2019

Ton Büchner

61 jaar

Audit Committee

02-03-2018

Elizabeth McNally

65 jaar

Director/Board Member

07-03-2025

Recente benoemingen: Novartis AG

21/01	Zura Bio benoemt Sandeep Kulkarni tot CEO	MT
21/01	Zura Bio kondigt wijzigingen aan in Chief Executive Officer, per 21 januari 2026	CI
20/01	Pfizer Limited kondigt wijzigingen aan in senior managementteam	CI
13/01	Zwitserse aandelen - Factoren om in de gaten te houden op 13 januari	RE
12/01	Avidity Biosciences, Inc. benoemt Stephen Moran tot Managing Director	CI
12/01	Kyverna Therapeutics, Inc. benoemt Christi Shaw tot uitvoerend voorzitter van de Raad van Bestuur, met ingang van 12 januari 2026	CI
08/01	Tango Therapeutics, Inc. kondigt wijzigingen aan in Raad van Bestuur en Directie	CI

Meer nieuws

Voormalige zaakvoerders en bestuurders: Novartis AG

Insider

Beklede functies

VanTot

Srikant T. Madhav Datar

Director/Board Member	01-01-2003	01-01-2021
Independent Dir/Board Member	01-01-2003	01-01-2021

Pierre Landolt

Director/Board Member	08-01-2010	02-03-2018
Independent Dir/Board Member	08-01-2010	02-03-2018
Corporate Officer/Principal	01-01-1996	08-01-2010

Joseph Jimenez

Director/Board Member	02-11-2009	08-01-2010
Chief Executive Officer	01-02-2010	01-01-2018
Corporate Officer/Principal	08-01-2010	26-01-2010

Jürgen Brokatzky-Geiger

Human Resources Officer	01-01-2005	06-03-2014
Corporate Officer/Principal	06-03-2014	01-10-2017

Wendelin Wiedeking

Director/Board Member	01-01-2003	25-02-2014
Independent Dir/Board Member	01-01-2003	25-02-2014
Corporate Officer/Principal	01-01-2003	08-01-2010

Rolf M. Zinkernagel

Director/Board Member	08-01-2010	25-02-2014
Independent Dir/Board Member	01-01-1999	25-02-2014
Corporate Officer/Principal	01-01-1999	08-01-2010

Alexandre F. Jetzer-Chung

Director/Board Member	08-01-2010	22-02-2011
Corporate Officer/Principal	01-01-1996	08-01-2010

Raymund Breu

Director of Finance/CFO

01-12-1996

01-01-2009

Hans Jörg Reinhardt

Chief Operating Officer	01-01-2008	01-01-2010
Corporate Officer/Principal	01-01-2006	01-01-2008
Chairman	01-01-2013	07-03-2025
Independent Dir/Board Member	01-01-2013	07-03-2025

William Brody

Director/Board Member	24-02-2009	-
Independent Dir/Board Member	25-08-2011	-

Urs Bärlocher

General Counsel

01-01-1999

31-08-2007

Thomas Ebeling

Corporate Officer/Principal

01-01-2000

01-01-2007

Karen Hübscher

Public Communications Contact

01-01-2000

01-01-2006

Andreas von Planta

Director/Board Member	01-01-2006	-
Independent Dir/Board Member	01-01-2006	-

Pierre F. Dodion

Sales & Marketing

01-01-2002

01-01-2006

François Martelet

Corporate Officer/Principal

01-07-2003

01-07-2005

Ian Garland

Corporate Officer/Principal

01-06-2005

Joachim P. H. Schupp

Corporate Officer/Principal

01-01-1985

01-10-2004

Ronen Tamir

Investor Relations Contact	28-10-2011	-
Public Communications Contact	28-10-2011	-
Corporate Officer/Principal	01-01-2004	28-10-2011

Marshall E. Reese

Corporate Officer/Principal

01-01-1999

01-01-2004

Mihael Polymeropoulos

Corporate Officer/Principal

01-01-1998

01-01-2003

Gilbert Wenzel

Corporate Officer/Principal

01-11-2000

01-01-2003

Paul Herrling

Chief Tech/Sci/R&D Officer

01-11-2002

Bruce F. Fleming

Corporate Officer/Principal

01-06-2001

01-06-2002

Silke Zentner

Public Communications Contact

05-04-2002

Fredrik Ollila

Corporate Officer/Principal

01-01-2002

Paolo Baroldi

Corporate Officer/Principal

01-01-1998

01-01-2002

James New

Corporate Officer/Principal

01-01-1999

Helmut Sihler

Director/Board Member

01-01-1996

Birgit Breuel

Corporate Officer/Principal

01-01-1996

Norman Hardman

Chief Tech/Sci/R&D Officer

01-01-1996

Peter Burckhardt

Director/Board Member	31-12-2009	-
Corporate Officer/Principal	01-01-1996	31-12-2009

John McKenna

Corporate Officer/Principal

01-01-1990

Ann Bailey

Public Communications Contact

01-01-1982

Gabor Veres

Corporate Officer/Principal

Siv Lindbratt Börjes

Corporate Officer/Principal

Adrian Hunter

Corporate Officer/Principal

MaryAnn DeMarco

Corporate Officer/Principal

David Metzger

Corporate Officer/Principal

Virginia Jamieson

Corporate Officer/Principal

Max Burger

Chairman	21-04-2010	-
President	17-07-2009	21-04-2010

Ian Stuart Charles Talmage

Corporate Officer/Principal

Michael Horne

Corporate Officer/Principal

John McAdoo

Corporate Officer/Principal

Ian Matthews

Corporate Officer/Principal

Geoff MacKay

Corporate Officer/Principal

Jutta Monika Heim

Corporate Officer/Principal

Peter Thomas Sany

Chief Tech/Sci/R&D Officer

William P. Keane

Corporate Officer/Principal

Nagesh Mahanthappa

Corporate Officer/Principal

Ann Moravick

Corporate Officer/Principal

Bobby Singh

Corporate Officer/Principal

Dominique Cheneval

Corporate Officer/Principal

John H. van Duzer

Corporate Officer/Principal

Randall S. Moore

Corporate Officer/Principal

Eric Wayne Evans

Director of Finance/CFO

Christoph Hüls

Corporate Officer/Principal

Ingrid Duplain

Corporate Secretary

Bruno Heynen

Corporate Secretary

Corinne Hoff

Public Communications Contact

Stuart J. Davie

Chief Tech/Sci/R&D Officer

Günter Frankenne

Director/Board Member

Karel Petrak

Corporate Officer/Principal

Peter E. Carlin

Corporate Officer/Principal

Terry Hart

Corporate Officer/Principal

Geert C. Mudde

Corporate Officer/Principal

Phil Johnson

Corporate Officer/Principal

Malcolm B. Cheetham

Comptroller/Controller/Auditor

James Phillips

Corporate Officer/Principal

Maike July-Grolman

Corporate Officer/Principal

Armin M. Kessler

Sales & Marketing

Hans-Georg Capraro

Corporate Officer/Principal

William J. Rutter

Director/Board Member

Gordon Wright

Corporate Officer/Principal

Jeret Bode

Corporate Officer/Principal

Rob Goshert

Corporate Officer/Principal

Jeffrey Hrkach

Corporate Officer/Principal

Peter Herold

Corporate Officer/Principal

Thomas Littke

Corporate Officer/Principal

John Slevin

Corporate Officer/Principal

Cees Winnips

Corporate Officer/Principal

Humphrey Harte

Corporate Officer/Principal

Leeftijdsdistributie van bedrijfsleiders

Ratio vrouwen/mannen

Man	20
Vrouw	8

Waarvan leden van het uitvoerend comité

Man	6
Vrouw	2

Waarvan bestuurders

Man	9
Vrouw	3

Herzieningen

Révisions CA 1 an

Révisions CA 4 mois

Révisions CA 1 mois

Révisions BNA 1 an

Révisions BNA 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Nee

Controverses sur les droits de l'Homme

Nee

Controverses Subventions fiscales

Nee

Conforme à la finance Islamique

Novartis AG is een van de wereldleiders in het ontwerpen, produceren en op de markt brengen van farmaceutische producten. De netto-omzet is als volgt over de therapeutische gebieden verdeeld - oncologie (29,3%) - immunologie (18,5%) - cardiovasculaire, renale en metabolische ziekten (17%); - neurowetenschap (9,4%). De resterende netto-omzet (25,8%) is afkomstig van contractproductie van farmaceutische producten. Eind 2024 had Novartis AG wereldwijd meer dan 30 productielocaties. De netto-omzet is geografisch als volgt verdeeld: Europa (30,9%), de Verenigde Staten (42%), Azië/Afrika/Australië (20%), Canada en Latijns-Amerika (7,1%).

Werknemers

75.883

Sector

Farmaceutische producten

Agenda

04/02 - Q4 2025 Cijferpublicaties

Meer informatie over het bedrijf